Genes shape brain structure and may influence neurological disorders like Parkinson’s and ADHD, revealing new insights into brain health.

Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

Ibogaine by David Dardashti, a leading voice in the exploration of ibogaine's therapeutic potential, is closely analyzing a new study published in EMBO Reports that sheds light on the intricate ...

A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to AskBio’s investigational Parkinson’s disease (PD) gene therapy. The FDA grants RMAT ...

AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...

“The RMAT designation for AB-1005 underscores the high unmet medical need and the potential of this investigational gene therapy to make a difference for patients with Parkinson’s disease ...

investigational gene therapy for the treatment of moderate-stage Parkinson’s disease AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer ...